NasdaqCM - Nasdaq Real Time Price USD

The Oncology Institute, Inc. (TOI)

Compare
0.4615 +0.0115 (+2.60%)
As of 2:10 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
342,713.0000
324,239.0000
252,483.0000
203,003.0000
187,515.0000
Cost of Revenue
285,270.0000
264,666.0000
200,390.0000
162,155.0000
150,636.0000
Gross Profit
57,443.0000
59,573.0000
52,093.0000
40,848.0000
36,879.0000
Operating Expense
119,566.0000
119,724.0000
124,100.0000
86,706.0000
45,076.0000
Operating Income
-62,123.0000
-60,151.0000
-72,007.0000
-45,858.0000
-8,197.0000
Net Non Operating Interest Income Expense
-7,319.0000
-6,777.0000
-4,082.0000
-320.0000
-347.0000
Other Income Expense
-3,597.0000
-16,176.0000
75,998.0000
34,580.0000
-6,271.0000
Pretax Income
-73,039.0000
-83,104.0000
-91.0000
-11,598.0000
-14,815.0000
Tax Provision
-80.0000
-36.0000
-243.0000
-671.0000
-493.0000
Net Income Common Stockholders
-57,768.0000
-67,877.0000
68.0000
-10,628.0000
-14,322.0000
Average Dilution Earnings
--
--
-17,048.0000
--
--
Diluted NI Available to Com Stockholders
-57,768.0000
-67,877.0000
-16,980.0000
-10,628.0000
-14,322.0000
Basic EPS
-0.81
-0.92
0.00
-0.16
-0.22
Diluted EPS
-0.81
-0.92
-0.21
-0.16
-0.22
Basic Average Shares
73,944.9490
73,748.6600
72,793.4970
66,230.6060
64,446.3770
Diluted Average Shares
73,944.9490
73,748.6600
80,605.6000
66,230.6060
64,446.3770
Total Operating Income as Reported
-62,123.0000
-77,018.0000
-81,951.0000
-45,858.0000
-8,197.0000
Total Expenses
404,836.0000
384,390.0000
324,490.0000
248,861.0000
195,712.0000
Net Income from Continuing & Discontinued Operation
-72,959.0000
-83,068.0000
152.0000
-10,927.0000
-14,322.0000
Normalized Income
-70,144.0866
-67,602.7023
-59,490.6300
-42,520.8971
-14,322.0000
Interest Expense
7,319.0000
6,777.0000
4,082.0000
320.0000
347.0000
Net Interest Income
-7,319.0000
-6,777.0000
-4,082.0000
-320.0000
-347.0000
EBIT
-65,720.0000
-76,327.0000
3,991.0000
-11,278.0000
-14,468.0000
EBITDA
-59,627.0000
-70,454.0000
8,402.0000
-7,937.0000
-11,290.0000
Reconciled Cost of Revenue
285,270.0000
264,666.0000
200,390.0000
162,155.0000
150,636.0000
Reconciled Depreciation
6,093.0000
5,873.0000
4,411.0000
3,341.0000
3,178.0000
Net Income from Continuing Operation Net Minority Interest
-72,959.0000
-83,068.0000
152.0000
-10,927.0000
-14,322.0000
Total Unusual Items Excluding Goodwill
-2,818.0000
-15,472.0000
75,497.0000
33,534.0000
--
Total Unusual Items
-2,818.0000
-15,472.0000
75,497.0000
33,534.0000
--
Normalized EBITDA
-56,809.0000
-54,982.0000
-67,095.0000
-41,471.0000
-11,290.0000
Tax Rate for Calcs
0.0000
0.0000
0.0002
0.0001
0.0000
Tax Effect of Unusual Items
-3.0866
-6.7023
15,854.3700
1,940.1029
--
12/31/2020 - 6/4/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PIII P3 Health Partners Inc.
0.6560
+5.13%
 
CCM Concord Medical Services Holdings Limited
0.5517
-7.37%
 
AVAH Aveanna Healthcare Holdings Inc.
2.9500
+18.95%
 
AONC American Oncology Network, Inc.
1.2300
0.00%
 
AIRS AirSculpt Technologies, Inc.
4.0800
-2.16%
 
IONM Assure Holdings Corp.
0.2351
-8.73%
 
BACK IMAC Holdings, Inc.
2.3600
+2.16%
 
ASTH Astrana Health, Inc.
40.10
+1.53%
 
PIIIW P3 Health Partners Inc.
0.0650
-10.34%
 
CCEL Cryo-Cell International, Inc.
8.60
+4.12%